Literature DB >> 9054772

Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.

E J Topol1, R M Califf, F Van de Werf, M Simoons, J Hampton, K L Lee, H White, J Simes, P W Armstrong.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9054772     DOI： 10.1161/01.cir.95.4.1072

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Antithrombin agents as adjuncts to thrombolytic therapy.

Authors:  J K French; H D White
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.

Authors:  Diane Warden; Madhukar H Trivedi; Tracy L Greer; Edward Nunes; Bruce D Grannemann; Viviana E Horigian; Eugene Somoza; Kolette Ring; Tiffany Kyle; José Szapocznik
Journal:  Contemp Clin Trials       Date:  2011-09-17       Impact factor: 2.226

Review 3.  Evidence from clinical trials: can we do better?

Authors:  Andrew D Siderowf
Journal:  NeuroRx       Date:  2004-07

Review 4.  Direct thrombin inhibitors as adjuncts to thrombolytic therapy.

Authors:  J K French; H D White
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

5.  Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities.

Authors:  Carol P Somkin; Andrea Altschuler; Lynn Ackerson; Dennis Tolsma; Sharon J Rolnick; Robert Yood; W Douglas Weaver; Ann Von Worley; Mark Hornbrook; David J Magid; Alan S Go
Journal:  Contemp Clin Trials       Date:  2008-03-04       Impact factor: 2.226

6.  Frailty in patients with acute coronary syndrome: comparison between tools for comprehensive geriatric assessment and the Tilburg Frailty Indicator.

Authors:  Izabella Uchmanowicz; Magdalena Lisiak; Radosław Wontor; Krystyna Łoboz-Grudzień
Journal:  Clin Interv Aging       Date:  2015-03-03       Impact factor: 4.458
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.